ZRX — Zortrax SA Share Price
- PLN11.22m
- PLN16.20m
- PLN15.04m
- 16
- 55
- 11
- 15
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.27 | ||
Price to Tang. Book | 4.63 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 1.02 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -187.22% | ||
Return on Equity | -101.34% | ||
Operating Margin | -784.73% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | PLNm | n/a | 1 | 20.08 | 40.15 | 15.04 | n/a | n/a | 146.93% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Zortrax SA, formerly Corelens SA, is a Poland-based company providing specialized solutions for the ophthalmic industry. The Company's business clients are public and private medical centers in Poland and the main product are intraocular lenses, which are used by doctors in cataract surgery. Other Company's products include surgical sets and disposable tools, viscoelastics and diagnostic equipment, also used by ophthalmologists during cataract surgery.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- February 26th, 2014
- Public Since
- April 20th, 2015
- No. of Employees
- 30
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Warsaw Stock Exchange
- Shares in Issue
- 120,422,500
- Address
- Lubelska 34, OLSZTYN, 10-409
- Web
- https://zortrax.com/
- Phone
- +48 896724001
- Auditors
- iAudit Sp. z o.o.
Upcoming Events for ZRX
Similar to ZRX
Airway Medix SA
Warsaw Stock Exchange
CM International SA
Warsaw Stock Exchange
Inventionmed SA
Warsaw Stock Exchange
Massmedica SA
Warsaw Stock Exchange
Medicalgorithmics SA
Warsaw Stock Exchange
FAQ
As of Today at 24:45 UTC, shares in Zortrax SA are trading at PLN0.09. This share price information is delayed by 15 minutes.
Shares in Zortrax SA last closed at PLN0.09 and the price had moved by -74.06% over the past 365 days. In terms of relative price strength the Zortrax SA share price has underperformed the FTSE Global All Cap Index by -76.61% over the past year.
There is no consensus recommendation for this security.
Find out moreZortrax SA does not currently pay a dividend.
Zortrax SA does not currently pay a dividend.
Zortrax SA does not currently pay a dividend.
To buy shares in Zortrax SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of PLN0.09, shares in Zortrax SA had a market capitalisation of PLN11.22m.
Here are the trading details for Zortrax SA:
- Country of listing: Poland
- Exchange: WSE
- Ticker Symbol: ZRX
Based on an overall assessment of its quality, value and momentum Zortrax SA is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Zortrax SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -51.23%.
As of the last closing price of PLN0.09, shares in Zortrax SA were trading -50.99% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Zortrax SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at PLN0.09.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Zortrax SA's directors